Podcasts about Ascent

Jose looks at how God moves into ever situation and breaks down the restoration process.

Barry covers our 5th and final Psalm of Ascent, which takes us in a new direction. Aside from being beautifully elegant and inspiring, this psalm is challenging and a bit of a comeuppance. Often when we think of worshipping God, we visualize a sacred space with little distractions and a lot of awe. However, this […]

Join Taylor and Jose as they sit down with Dr. Carl Follingstad, a Bible Translation Consultant with Wycliffe, for a thoughtful conversation on constrained ambition—and how God works powerfully through it.

Chapter 122 is here to ask you - What Would Jonathan Christ Do? Join Sophie, Sam, and Hannah as they discuss plot happening offscreen, how sleep and/or lack of romantic competition makes everyone nicer, and debate the existence of The Wand.

Psalm 127 From the Psalms of Ascent, Ascending with Christ. Sermon Notes & Liturgy Summer Reading Guide Christ City Church, Dallas, Texas July 27th, 2025

Psalm 124 offers a song of salvation for all of God's people. But could cynicism or self-sufficiency be preventing you from joining the song?

While we take a season break, we're bringing back this conversation with Rus Devora Wallen, who shares her own experience with a stroke, and lessons from her clients on how the greatest descents in our lives are often a preparation and a catalyst for unparalleled ascent. Find more of Rus Devorah's work on toratherapeutics.com ||* * * * * * *To inquire about sponsorship & advertising opportunities, please email us at info@humanandholy.comTo support our work, visit humanandholy.com/sponsor.Find us on Instagram @humanandholy & subscribe to our channel to stay up to date on all our upcoming conversations ✨Human & Holy podcast is available on all podcast streaming platforms. New episodes every Sunday & Wednesday on YouTube, Spotify, Apple Podcasts, and Google Podcasts.* * * * * * *TIMESTAMPS0:00 - Introduction 1:55 - Meet Devora Wallen: Licensed Clinical Social Worker3:25 - Understanding Yerida L'Tzorech Aliyah (Descent for Ascent)5:46 - The Stroke Story: Shavuos Morning Crisis7:26 - Emergency Signs: When Something Goes Wrong9:50 - Hospital Experience & Spiritual Tools12:15 - The Turning Point: Gratitude & Second Life13:44 - Physical Transformation: Better Than Age 2515:26 - Managing High Energy Positively18:11 - Client Story: Postpartum Psychosis Recovery21:07 - Mirror Neurons & Relationship Dynamics23:41 - Unexpected Healing: Tourette's Syndrome Improvement24:44 - The Three-Legged Stool: Mind, Body, Soul26:36 - Depression 29:02 - Caring for Aging Parents & Life Changes30:43 - The Bike Ride Breakthrough31:41 - Moving Creates Motivation34:14 - Mitzvah Leads to Mitzvah35:20 - Three-Legged Stool Method Explained37:35 - Bedtime Breathing Contest Technique39:45 - Basic Breathing for Beginners41:12 - Live Meditation Demonstration Begins45:01 - Post-Meditation Discussion & Benefits46:54 - Mental Muscle Training & Daily Practice48:14 - Meditation as Mental Exercise, Not Relaxation49:30 - Closing Thoughts

Taylor and Jose sit down with Dr. Shawn Stoever to look at what it means to build your life and family on God.

Dr. Carl Follingstad continues the series looking at how God uses constrained ambitions.

Last Cholent Pre-Nine Days Kumzitz

Message 3 of 8 in the series “Rise: The Psalms of Ascent” by Christian Williams.

Phil Smith sharing at Grace on July 27, 2025

With an uptick in licensing deals and promising data emerging from China-based biopharmas, especially in oncology, it’s clear the country is poised to play a major role in life sciences for the foreseeable future. In this week’s episode of "The Top Line," we trace China’s ascent in R&D and drug discovery and examine how U.S. and European drugmakers are capitalizing on the momentum through a surge in licensing activity. Fierce Pharma’s Fraiser Kansteiner sits down with Mark Lansdell, director at Evaluate, to break down the policies fueling China’s growth, how global companies are engaging with Chinese assets and which modalities and indications are commanding the most attention. To learn more about the topics in this episode: China approves 4 new drugs, including a global first-in-class medicine With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report China proposes shorter clinical trial reviews in efforts to accelerate drug development See omnystudio.com/listener for privacy information.

Cooper will run for US Senate; foster families needed at Char-Meck Animal Control; Ascent signs Charlotte star

In an era where tons of games are dying out, Pixelmon is building a world expanding IP. Games (yes, multiple), comics, tv shows, and more...We're getting under the hood to break it all down

Have a Social with the Saints! Receive encouragement for your daily life as we meet & discuss the first people to be beatified as a family, including an unborn child in the womb. Who were they? How will they help and inspire you? Be encouraged and inspired for your daily life! Get a free quote card and pamphlet of the Bl. Ulma Family here. We invite you to share them with friends and family. We want to hear from you! What struck you about the Bl. Ulma Family? Please send us your feedback to join the conversation by email at ministry@pilgrimcenterofhope.org The official Socials with the Saints theme song is “Hero's Ascent” by Chris Haugen. Used with permission. Thanks for listening and remember, you are never alone in the communion of the saints! May God bless you. Help us spread hope!

Barry covers another Psalm of Ascent, a reminder of how and why we worship. Psalm 132 turns the idea of coming to worship on its head as we are not approaching God, hoping to get his attention so he will care about the things we care about. Instead, we find that God has already promised […]

Brandon Tierney unleashes a passionate and insightful breakdown as the New York Giants officially name their starting quarterback. Tierney dives deep into the implications of the decision, analyzing whether the chosen signal-caller is truly the right fit for Big Blue's future and if it aligns with their developmental goals, particularly for the younger talent on the roster. He'll dissect the competition, offer bold predictions on player outcomes, and challenge the Giants' strategic approach to their quarterback depth chart in a no-holds-barred discussion.

Allison Buccola The Ascent Authors on the Air by Authors on the Air Global Radio Network

Charles Eisenstein (born 1967) is an American public speaker, author, and activist. His books include The Ascent of Humanity, Sacred Economics, and The More Beautiful World Our Hearts Know is Possible.Eisenstein's work covers a wide range of topics, including the history of human civilization, economics, spirituality, and the ecology movement. Key themes explored include anti-consumerism, interdependence, and how myth and narrative influence culture. According to Eisenstein, global culture is immersed in a destructive "story of separation", and one of the main goals of his work is to present an alternative "story of interbeing". Much of his work draws on ideas from Eastern philosophy, the spiritual teachings of various indigenous peoples, and New Age themes.https://charleseisenstein.org

Charles Eisenstein is a teacher,  public speaker, and author who examines the unspoken narratives that direct our society and our lives. His work covers a wide range of topics, including the history of human civilization, consciousness, economics, spirituality, interdependence, ecology, and how myth and story influence culture. His newest book, The Coronation, was released in the summer of 2022. He is the author of The More Beautiful World our Hearts Know is Possible, Sacred Economics, and The Ascent of Humanity.Episode Highlights▶ Why “the rehearsal is over” and it's time to live our psychedelic insights▶ How feelings of despair stem from ignoring deeper truths we've already seen▶ The power of small, heart-led actions to create meaningful change▶ Why real transformation starts with connection, not productivity▶ Psychedelics as medicine for the illness of separation and disconnection▶ Integration through community and the need for collective story-holding▶ How crisis moments offer powerful opportunities for conscious choice▶ The shadow side of doomsday narratives and how to shift beyond them▶ Rethinking "right" and "wrong" in psychedelic use, cultural gatekeeping, and humility▶ How psychedelic medicine is quietly reaching power structures▶ The Sanity Project as a sanctuary for anchoring a new cultural storyCharles Eisenstein's Links & Resources▶ Website: https://charleseisenstein.org/courses/sanity-project/▶ Substack: https://charleseisenstein.substack.com/▶ Instagram: https://instagram.com/charles_eisenstein▶ Facebook:https://www.facebook.com/charleseisensteinauthor  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz ▶ Join the free Psychedelics & Purpose Community: / psychedelicsandsacredmedicines

Psalm 126 From the Psalms of Ascent, Ascending with Christ. Sermon Notes & Liturgy Summer Reading Guide Christ City Church, Dallas, Texas July 20th, 2025

Charles Eisenstein (born 1967) is an American public speaker, author, and activist. His books include The Ascent of Humanity, Sacred Economics, and The More Beautiful World Our Hearts Know is Possible.Eisenstein's work covers a wide range of topics, including the history of human civilization, economics, spirituality, and the ecology movement. Key themes explored include anti-consumerism, interdependence, and how myth and narrative influence culture. According to Eisenstein, global culture is immersed in a destructive "story of separation", and one of the main goals of his work is to present an alternative "story of interbeing". Much of his work draws on ideas from Eastern philosophy, the spiritual teachings of various indigenous peoples, and New Age themes.https://charleseisenstein.org

What if the next great investment opportunity lies not on Earth—but in orbit? Hosted by Michelle Martin, this episode explores how space is transforming into the next trillion-dollar economy. Dr. Kartik Sheth, Chairman of the Council of SST Think Tank and a former NASA scientist, discusses Singapore’s emerging role, why Asia is uniquely poised to lead, and which space economy sectors are attracting global capital. From space-based energy to the Mars economy, moonshot thinking and more, discover where your business and portfolio could boldly go next.See omnystudio.com/listener for privacy information.

On this episode of the Ruff Talk VR podcast we are kicking off the week talking all the latest VR news! Including Dungeons of Eternity teasing their next “Mythic Promotion” update to come with their PCVR launch, a release date for Besiege VR, a Clone Drone in the Hyperdome update, a release date for Frost Survival VR, news on Ascent Quest, Forefront gameplay info, The Pirate: Republic of Nassau, Ghost Town on PCVR, Horror In The Library, Brazen Blaze going free to play, and the upcoming VR Games through the rest of July! Big thank you to all of our Patreon supporters! Become a supporter of the show today at https://www.patreon.com/rufftalkvrDiscord: https://discord.gg/9JTdCccucSPatreon: https://www.patreon.com/rufftalkvrIf you enjoy the podcast be sure to rate us 5 stars and subscribe! Join our official subreddit at https://www.reddit.com/r/RuffTalkVR/0:00 - Episode Start6:40 - Space Tomato 11:25 - Dungeons of Eternity "Mythic Promotion" update24:15 - Besiege VR release date29:50 - Clonedrone in the Hyperdome "Skyscraper Update"32:30 - Frost Survival VR release date41:50 - Ascent Quest44:40 - Forefront new gameplay52:55 - The Pirate: Republic of Nassau 56:00 - Ghost Town PCVR Launch58:10 - Horror In The Library VR1:01:00 - Brazen Blaze goes Free to Play1:04:00 - Upcoming VR GamesSend us a text to the Ruff Talk VR fan mail line!Support the show

What do you do when it feels like your faith has backfired on you in front of a watching world? Join us as we explore this question in Psalm 123.

In this episode, CancerNetwork® spoke with breast oncologists Heather McArthur, MD; Erika Hamilton, MD; Hope Rugo, MD; and Paolo Tarantino, MD, PhD, about advances in breast cancer. These developments included recent drug approvals and ongoing research for therapeutic approaches, particularly in the areas of antibody-drug conjugates (ADCs) and CDK4/6 inhibitors, based on presentations they gave at the 25th Annual International Congress on the Future of Breast Cancer (IBC) East in New York City. Initially, McArthur, Komen Distinguished Chair in Clinical Breast Cancer Research at the Harold C. Simmons Comprehensive Cancer Center, discussed immunotherapy use in high-risk triple-negative and HER2-positive disease, the evolving role of adjuvant CDK4/6 inhibition in HER2-negative breast cancer, and potentially transformative advancements in early breast cancer treatment.  She highlighted the FDA approval for pembrolizumab (Keytruda) in early-stage triple-negative breast cancer, promising clinical trials in estrogen receptor (ER)–positive high-risk early-stage breast cancer, and data from an investigator-initiated trial to treat HER2-positive disease. Additionally, she highlighted an 8.5% improvement in pathological complete response with pembrolizumab added to immunotherapy in the phase 3 KEYNOTE-756 trial (NCT03725059), adding that a further event-free survival benefit may complicate the landscape for CDK4/6 inhibition based on lung and liver toxicities associated with the coadministration of these inhibitors with immunotherapy.1 McArthur expressed further excitement for ADC-based combinations for triple-negative disease, as well as in the high-risk residual disease setting. In addition, she highlighted potential advancements in de-escalation strategies and further considerations for ADCs in the HER2-positive and hormone receptor (HR)–positive spaces. Then, Hamilton, director of Breast Cancer and Gynecologic Cancer Research at the Sarah Cannon Research Institute, highlighted emerging therapies for early breast cancer, as well as her use of datopotamab deruxtecan-dlnk (dato-DXd; Datroway) and fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) given their recent approvals in various breast cancer subtypes. She also touched upon challenges with respect to the implementation of new therapies for early breast cancer into clinical practice. She initially highlighted new data from the phase 3 VERITAC-2 trial (NCT05654623) presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.2 Specifically, findings showed that vepdegestrant, an oral proteolysis-targeting chimera (PROTAC), exhibited an efficacy advantage over fulvestrant (Faslodex) in patients with ESR1-mutant ER-positive, HER2-negative advanced or metastatic disease. Moreover, she highlighted data from the phase 3 DESTINY-Breast09 (NCT04784715) of T-DXd in various combinations for patients with HER2-positive metastatic breast cancer.3 Hamilton further highlighted her implementation of T-DXd into clinical practice, citing her use of the agent in patients with metastatic disease, including those with HER2-low and HER2-ultralow breast cancer. She further differentiated dato-DXd from T-DXd, suggesting that they were different classes of drugs due to their different targets: TROP2 vs HER2. She concluded by highlighting an unmet need regarding sustained benefit from endocrine therapy in HR-positive disease, as well as for ADC sequencing and mechanisms of resistance. Afterward, Rugo, division chief of Breast Medical Oncology, Women's Cancer Program Director, and professor in the Department of Medical Oncology and Therapeutics Research at City of Hope, discussed efficacy and safety considerations for CDK4/6 inhibitors in early breast cancer treatment. Specifically, she highlighted their high tolerability despite adverse effects and costs associated with their use. Rugo further touched upon a reduction of recurrence rates associated with CDK4/6 inhibition, although longer-term follow-up data were warranted to optimize the duration of therapy and elucidate survival outcomes. Finally, Tarantino, a research fellow at the Dana-Farber Institute, concluded by discussing sequencing strategies for ADCs, as well as which breast cancer settings or patient populations will experience the greatest impact with this treatment modality. Tarantino discussed his use of the “sandwich strategy,” where he switches the mechanism of action of treatment after using a TOPO1 ADC. Furthermore, Tarantino highlighted data from the DESTINY-Breast09 and phase 3 ASCENT-04 (NCT06100874) trials, which displayed the enhanced efficacy of 2 ADC combination therapies.4 He concluded by discussing future considerations for combining multiple ADCs. References 1. Cardoso F, O'Shaughnessy J, Liu Z, et al. Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trial. Nat Med. 2025;31(2):442-448. doi:10.1038/s41591-024-03415-7 2. Hamilton E, De Laurentiis M, Jhaveri K, et al. Vepdegestrant, a PROTAC estrogen receptor (ER) degrader, vs fulvestrant in ER-positive/human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer: results of the global, randomized, phase 3 VERITAC-2 study. J Clin Oncol. 2025;43(suppl 17):LBA1000. doi:10.1200/JCO.2025.43.17_suppl.LBA1000 3. Tolaney S, Jiang Z, Zhang Q, et al. Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): interim results from DESTINY-Breast09. J Clin Oncol. 2025;43(suppl 17):LBA1008. 4. Tolaney SM, de Azambuja E, Kalinsky K, et al. Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study. J Clin Oncol. 2025;43(suppl 17):LBA109. doi:10.1200/JCO.2025.43.17_suppl.LBA109

Compass Bible Church Treasure Valley is located in Meridian, Idaho. For more information about Compass Bible Church go to https://www.compassbible.tv/To follow our daily Bible reading plan and podcast go to https://www.revivalfromthebible.com/

Your yet season is upon you!

Your yet season is upon you!

Dr. Shawn Stoever takes a look at how we are designed for relationship with one another and what makes a healthy home.

Welcome to The Village Church. Thank you for joining our live stream. We are beautiful and broken people connected in Jesus, extending His love.

Welcome to The Village Church. Thank you for joining our live stream. We are beautiful and broken people connected in Jesus, extending His love.

Message 2 of 8 in the series “Rise: The Psalms of Ascent” by Christian Williams.

In this sermon series on The Psalms of Ascent, Pastor Nathan teaches that this is about a journey; the upward climb to Jerusalem. The upward way is not always smooth, but is sure and leads to the Lord. Pastor asks: “What are the ingredients to the blessed life?” The Lord loves to bless us with […]

Josh Sebo (COO of OfferVault), Adam Young (CEO of Ringba), industry legend Harrison Gevirtz and special guest Haiphie Hua (Head of Strategic Partnerships at CodeClouds) discuss:- A Legacy of Resilience: How Haiphie's Parents Escaped Vietnam- From Day One to VP: Haiphie's Ascent from the Bottom to the Top- Offer Creation Over Branding: The Importance of Backend Operations- Bootstrapped Expertise: Learning in the Trenches- CodeClouds & Consulting: How to Build Profitable Offers, Funnels & Custom Software- Affiliates as Offer Owners: How Affiliates Should be Thinking- The Evolving Landscape: Major Shifts and What's Next- Scaling Starts After The Sale: Focus on LTV, Retention & Backend FlowsFollow Us:OfferVault:WEBSITE: https://www.offervault.com/FACEBOOK: https://www.facebook.com/offervaultINSTAGRAM: https://www.instagram.com/offervaultmarketing/TWITTER: https://www.twitter.com/offervaultLINKEDIN: https://www.linkedin.com/company/offer-vault/Adam Young: RINGBA: https://www.ringba.comRINGBA's INNER CIRCLE: https://try.ringba.com/inner-circle/FACEBOOK: https://www.facebook.com/ringbaINSTAGRAM: https://www.instagram.com/adamyoung/TWITTER: https://www.twitter.com/arbitrageLINKEDIN: https://www.linkedin.com/in/capitalistHarrison Gevirtz:INSTAGRAM: https://www.instagram.com/affiliate/LINKEDIN: https://www.linkedin.com/in/harrisongevirtz/Haiphie Hua:CODECLOUDS: https://www.codeclouds.com/INSTAGRAM: https://www.instagram.com/haiphiehua/LINKEDIN: https://www.linkedin.com/in/haiphiehua/

What does it take to turn equations into breakthroughs? The journey begins with basic science—quiet, patient, and often overlooked for decades. It starts even earlier, in the classroom. As the 2025 International Congress of Basic Science (ICBS) convenes in Beijing, the world is watching: How does China transform fundamental research into real-world innovation? And more critically—how is it cultivating the next generation of STEM leaders to push boundaries further? On the show: Heyang, Steve Hatherly & Guo Yan

Have you ever wondered why we pray? We say that God knows everything before it happens, and we believe he is always good (to the level of perfection, in fact), so why do we show up asking for things to change at all? In Psalm 130, our third Psalm of Ascent, Barry talks about the […]

Amit Goswami, Ph.D. Professor, researcher, bestselling author, Quantum Science Pioneer, spiritual practitioner. Amit Goswami, PhD, is a retired professor from the physics department of the University of Oregon (1968 to 1997). He is a renowned pioneer of the new paradigm of quantum science based on the primacy of consciousness. In 2009, Amit started a movement called Quantum Activism, now gaining ground in North and South America (where he has founded Quantum Academy), Europe, and India. At the same time, he has established the Center for Quantum Activism (CQA) with headquarters in the USA. In 2019, he and his collaborators established an education wing of CQA called Quantum Activism Vishwalayam (Home of the World), acting as Department of Quantum Science at the University of Technology in Jaipur, India. They developed a Master program in Psychology, and also PhD programs in Psychology, Yoga and Naturopathy, Economics, Management, and Sociology. All these are based on principles of integration of science and spirituality that Amit has developed over the years. It is an international program of transformative education. Goswami has written several groundbreaking popular books based on research on quantum science and consciousness, amongst them, Quantum Integrative Medicine, Hero's Journey Quantum Style, The Quantum Brain, The Return of the Archetypes, Quantum Spirituality, and The Re-enchantment of the Reality You Live (all of these, with Valentina R. Onisor, MD), Quantum Psychology and the Science of Happiness (with Sunita Pattani, MS), The Self-Aware Universe, The Quantum Doctor, Physics of the Soul, Quantum Creativity, and The Everything Answer Book. His latest book, The Ascent of Humanity has just been released. Amit was featured in the movie What the Bleep Do We Know? and the documentaries The Dalai Lama Renaissance, The Quantum Activist. His most recent documentary was launched in 2024 in Brazil: The power of the subtle. He is a spiritual practitioner and calls himself a quantum activist in search of Wholeness.

Forza Horizon 5 sold 2 million units in a month on PS5, there's a whole Subnautica 2 saga, the Donkey Kong Bananza director says he's aware of occasional performance issues, and Nintendo and Universal are planning a Donkey Kong movie. Also: video podcasts, politics, tattoo updates, slippers and more. Games discussed: Tony Hawk's Pro Skater 3+4, Death Stranding 2: On the Beach, Two Point Museum, The Ascent. Support Patreon Store Contact Website Contact form Discord Bluesky Threads Instagram Facebook Follow TCGS on Bluesky David on Bluesky Sean on Bluesky Mat on Bluesky James on Bluesky Watch Twitch YouTube Listen Spotify Apple Podcasts Pocket Casts Credits Music by Nick Parton Art by Dave Chong

Taylor and Jose are Joined by Worship Pastor Joel Hernandez to look more at how help truly comes from the Lord.

Psalms 124 & 125 from the Psalms of Ascent, Ascending with Christ. Sermon Notes & Liturgy Summer Reading Guide Christ City Church, Dallas, Texas July 13th, 2025

Pastor Nick preaches on a Psalm of Ascent, considering the ways that God restores our joy, and teaching that according to scripture joy is simultaneously a gift from God and a command to the saints. 

Worship Pastor Joel Hernandez continues the series looking at Psalm 121.

In this sermon, we explore a psalm that is difficult to resonate with, but can help us recover something critical to our calling.

We're all on a journey—toward God and with God. In this message, Pastor Danny de Armas unpacks Psalm 120, the first of the “Songs of Ascent,” which marks the beginning of a pilgrim's journey with one essential step: repentance. These ancient songs were sung by travelers heading to Jerusalem, and they reflect the spiritual reality we live today. Repentance means turning away from the lies that lure us—and from the people who distract us from God's path. With honest insight and personal stories, Pastor Danny helps us see that this journey isn't about perfection, but about direction. Every step we take toward God brings us closer to home. (07/06/2025)

At a high school track meet I was working as an official this spring, a young man came up to me and commented about my ever-present Yankees cap and mentioned that his uncle had once played for the Bronx Bombers. I figured it would be some nobody, but it turned out to be Hall of Famer and Yankees legend Goose Gossage. As Avi Rahmani of Ralston Valley H.S. in Arvada, Colo., and I got to know each other, I learned about his amazing story of contracting a rare form of cancer, leading to having a kidney removed, and eight agonizing months of chemotherapy and isolation in the hospital. He came out of that ordeal healthy and with a new attitude toward life and a renewed enthusiasm for running. Any recovery has its share of road bumps, and Avi's took a different turn. He developed the same uncommon vocal cord dysfunction that you heard about in our episode a few weeks ago with high school runners Benji Anderson and Peak Performance teammate Bobby Kieswetter, who got him directed to their doctor at Denver's National Jewish hospital. This brave young man discusses the challenges that he and his family stood up to during his serious illness, and Avi's life is definitely on the upswing now as he prepares for his senior year. You'll come away with a renewed sense of optimism when you hear this exceptionally nice guy's upbeat attitude and about how he looks forward to being a leader on his high school cross country team and having a long, healthy life that will make a difference in the world.Avi RahmaniInstagram and Threads @avi.rahmaniBill Stahlsilly_billy@msn.comFacebook Bill StahlInstagram and Threads @stahlor and @we_are_superman_podcastYouTube We Are Superman PodcastPlease support Team Leadville and Warriors' Ascent help prevent veteran suicide! Donate here:https://give.classy.org/BillStahl2025Thank you!Subscribe to the We Are Superman Newsletter!https://mailchi.mp/dab62cfc01f8/newsletter-signupSubscribe to our Substack for my archive of articles of coaching tips developed from my more than three decades of experience, wild and funny stories from my long coaching career, the wit and wisdom of David, and highlights of some of the best WASP episodes from the past that I feel are worthwhile giving another listen.Search either We Are Superman Podcast or @billstahl8